These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2260472)

  • 1. Microvesicular fatty liver in rats with resembling Reye's syndrome induced by 4-pentenoic acid.
    Sakaida N; Senzaki H; Shikata N; Morii S
    Acta Pathol Jpn; 1990 Sep; 40(9):635-42. PubMed ID: 2260472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of mitochondrial fatty acid oxidation in pentenoic acid-induced fatty liver. A possible model for Reye's syndrome.
    Thayer WS
    Biochem Pharmacol; 1984 Apr; 33(8):1187-94. PubMed ID: 6712730
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of the features of Reye's syndrome in rats with 4-pentenoic acid.
    Glasgow AM; Chase HP
    Pediatr Res; 1975 Mar; 9(3):133-8. PubMed ID: 1121419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol protects against experimental induced Reye's syndrome by prohibition of oxidative stress and restoration of complex I activity.
    Abdin A; Sarhan N
    Can J Physiol Pharmacol; 2014 Sep; 92(9):780-8. PubMed ID: 25162205
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevention of 4-pentenoic acid-induced liver injury in rats by 16,16-dimethyl PGE2.
    Hidaka T; Inokuchi T; Nakamura Y; Kotegawa M; Sugiyama M; Ogura R
    Exp Mol Pathol; 1991 Oct; 55(2):135-42. PubMed ID: 1936211
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of an animal model of a Reye-like syndrome caused by Margosa oil.
    Sinniah D; Schwartz PH; Mitchell RA; Arcinue EL
    Pediatr Res; 1985 Dec; 19(12):1346-55. PubMed ID: 4080457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in plasma amino acids and hepatic enzymes in the 4-pentenoic acid model of Reye's syndrome.
    Hart MA; Swisher JA; Caspers ML
    Biochem Pharmacol; 1989 May; 38(10):1696-8. PubMed ID: 2730684
    [No Abstract]   [Full Text] [Related]  

  • 8. Carnitine metabolism in rats with 4-pentenoic acid induced fatty liver.
    Yuge K
    Acta Paediatr Jpn; 1990 Aug; 32(4):449-55. PubMed ID: 2288228
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mitochondrial permeability transition: a new pathophysiological mechanism for Reye's syndrome and toxic liver injury.
    Trost LC; Lemasters JJ
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1000-5. PubMed ID: 8819478
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatty liver in sudden childhood death. Implications for Reye's syndrome?
    Bonnell HJ; Beckwith JB
    Am J Dis Child; 1986 Jan; 140(1):30-3. PubMed ID: 3942104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of L-carnitine supplementation in 4 pentenoic acid treated rats.
    Sugimoto T; Woo M; Nishida N; Araki A; Murakami K; Kobayashi Y
    Brain Dev; 1990; 12(4):417-22. PubMed ID: 2240462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental models of Reye's syndrome.
    Saratikov AS; Vengerovskii AI; Arbuzov AG; Chuchalin VS; Chervyakova MB; Sukhodolo IV
    Bull Exp Biol Med; 2000 Apr; 129(4):400-2. PubMed ID: 10977933
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of peroxidized polyunsaturated fatty acids on mitochondrial function and structure: pathogenetic implications for Reye's syndrome.
    Brown RE; Bhuvaneswaran C; Brewster M
    Ann Clin Lab Sci; 1988; 18(4):337-43. PubMed ID: 2900617
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The hepatic lesion in Reye's syndrome.
    Bove KE; McAdams AJ; Partin JC; Partin JS; Hug G; Schubert WK
    Gastroenterology; 1975 Sep; 69(3):685-97. PubMed ID: 1158086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic changes in a rabbit model of Reye's syndrome.
    Trauner DA
    Pediatr Res; 1982 Nov; 16(11):950-3. PubMed ID: 7155664
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Periportal hepatic necrosis in Reye's syndrome. One case in a review of eight patients.
    Bentz MS; Cohen C
    Am J Gastroenterol; 1980 Jan; 73(1):49-53. PubMed ID: 7377172
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic metabolic alterations in rats treated with low-dose endotoxin and aspirin: an animal model of Reye's syndrome.
    Kilpatrick LE; Polin RA; Douglas SD; Corkey BE
    Metabolism; 1989 Jan; 38(1):73-7. PubMed ID: 2909830
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of liver ultrastructure in salicylate intoxication and Reye's syndrome.
    Partin JS; Daugherty CC; McAdams AJ; Partin JC; Schubert WK
    Hepatology; 1984; 4(4):687-90. PubMed ID: 6745858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Reye's syndrome].
    Aicardi J; Diebler C
    Arch Fr Pediatr; 1976 Nov; 33(G):847-52. PubMed ID: 795392
    [No Abstract]   [Full Text] [Related]  

  • 20. [Therapeutic effect of hepatoprotectors in experimental Reye syndrome].
    Vengerovskiĭ AI; Sukhodolo IV; Chuchalin VS; Arbuzov AG; Cherviakova MB; Mel'nik IuIu; Grishina EI; Fedoreev SA; Saratikov AS
    Eksp Klin Farmakol; 2000; 63(5):68-71. PubMed ID: 11109534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.